Comments on: BridgeBio Pharma Announces Publication in the New England Journal of Medicine of Phase 2 PROPEL 2 Study of Infigratinib for Children Living with Achondroplasia https://insideout.vn/bridgebio-pharma-announces-publication-in-the-new-england-journal-of-medicine-of-phase-2-propel-2-study-of-infigratinib-for-children-living-with-achondroplasia/ Inside Out Mon, 18 Nov 2024 10:54:06 +0000 hourly 1 https://wordpress.org/?v=6.7